Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$62.39 - $113.8 $30,571 - $55,762
490 Added 15.84%
3,583 $407,000
Q3 2022

Oct 13, 2022

BUY
$58.92 - $84.67 $182,239 - $261,884
3,093 New
3,093 $201,000
Q2 2022

Jul 18, 2022

SELL
$79.4 - $116.36 $177,697 - $260,413
-2,238 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$98.56 - $119.91 $220,577 - $268,358
2,238 New
2,238 $209,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Von Berge Wealth Management Group, LLC Portfolio

Follow Von Berge Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Von Berge Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Von Berge Wealth Management Group, LLC with notifications on news.